A Win For Liminal BioSciences Inc.
Liminal BioSciences Inc. (LMNL:NASDAQ) jumped higher at $6.72, representing a gain of 77.8%. On Wed, Apr 05, 2023, LMNL:NASDAQ touched a New 2-Week High of $6.72. The stock got featured on our News Catalysts scanner on Wed, Apr 05, 2023 at 09:21 AM in the 'ACQUISITION' category. From Wed, Mar 22, 2023, the stock recorded 33.33% Up Days and 20.00% Green Days
About Liminal BioSciences Inc. (LMNL:NASDAQ)
Liminal Biosciences Inc is a global biopharmaceutical corporation supplying technologies for Bioseparations while also developing its orphan drugs, plasma-derived therapeutics and small-molecule therapeutic products targeting unmet medical needs in the field of fibrosis, autoimmune disease/inflammation, and cancer. The company also offers drug purification of biologics, drug development, proteomics and the elimination of pathogens.
Top 10 Gainers:
- Jowell Global Ltd. (JWEL:NASDAQ), 146.47%
- Liminal BioSciences Inc. (LMNL:NASDAQ), 77.78%
- InflaRx N.V. (IFRX:NASDAQ), 61.8%
- Nuburu Inc. (BURU:NYSEMKT), 56.99%
- Scilex Holding Company Com (SCLX:NASDAQ), 56.57%
- Virgin Orbit Holdings Inc. (VORB:NASDAQ), 34.23%
- TransCode Therapeutics Inc. (RNAZ:NASDAQ), 31.76%
- Freight Technologies Inc Com (FRGT:NASDAQ), 30.41%
- Creatd Inc. (CRTD:NASDAQ), 26.62%
- Vallon Pharmaceuticals Inc. (VLON:NASDAQ), 25.71%